DRG uses cookies to improve your experience on this website. Some of the cookies we use are essential for parts of the website to operate. Please be aware that if you continue without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.

Research & Reports

Searching in Biopharma (1970)

Peripheral Arterial Disease | Epidemiology | Middle East & Africa

Peripheral Arterial Disease | Epidemiology | Middle East & Africa

Thank you!

Your request has been received by DRG. A represantative will contact you shortly to provide more details on the research and data contained in this report and ensure that it will meet your current research needs.

DRG Epidemiology’s coverage of peripheral arterial disease (PAD) comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report the prevalence of PAD for each country, as well as annualized case counts projected to the national population.

Most patient populations in the mature pharmaceutical markets are forecast over a period of 20 years; in other countries, forecasts cover a 10-year period. In addition to forecasting prevalent patient populations, we calculate the number of drug-treatment opportunities in specific lines of therapy in the mature pharmaceutical markets.

DRG Epidemiology’s PAD forecast will answer the following questions:

  • How will changes in the levels of exposure to known risk or protective factors affect the number of people living with PAD?
  • Of all people with PAD, how many in each country have been formally diagnosed?
  • Of all people diagnosed with PAD, how many in the mature pharmaceutical markets are drug-treated?
  • How will demographic trends, such as population aging and improving life expectancy, affect the epidemiology of PAD over the forecast period?

All forecast data are available on the DRG Insights Platform in tabular format, with options to download to MS Excel. All populations are accompanied by a comprehensive description of the methods and data sources used, with hyperlinks to external sources. A summary evidence table generated as part of our systematic review of the epidemiological literature is also provided for full transparency into research and methods. In addition, we provide a graph of the patient flow between or within different disease states for the mature pharmaceutical markets. These patient flows are provided at the regional level but may be requested for any specific country or forecast year.

DRG Epidemiology provides at least ten years of forecast data for the following PAD patient populations:

  • Total prevalent cases.
  • Diagnosed prevalent cases.

… and many more (details available on request).

Note: Coverage may vary by country and region.

Table of contents

  • Middle East & Africa
    • Introduction
      • Overview
        • Total Prevalence of Peripheral Arterial Disease per 100 People Aged 40+ in 2017 and 2027
        • Relative Sizes of the Factors Contributing to the Trend in Total Prevalent Cases of Peripheral Arterial Disease over the Next Ten Years
        • Number of Additional Total Prevalent Cases of Peripheral Arterial Disease in 2027 in the Countries Under Study due to Trends in Risk or Survival
      • Key Findings
    • Epidemiology Data
    • Methods
      • Total Prevalent Cases
    • Reference Materials
      • Bibliography
      • Literature Review
      • Risk-Protective Factors

Already a Client? Log in to access this report.

  • Pub Date: August 2017
  • Author(s): Ruchika Sharma, MPH; Dr. Ravdeep Kaur, MPH
  • Ruchika Sharma joined Decision Resources Group as Associate Epidemiologist in May 2016. She performs fully documented systematic reviews of both published and grey literature on the epidemiology of assigned diseases and their risk factors to estimate incidence/prevalence over a 10-30 year period. She produces analyses for pharmaceutical drug developers on the descriptive epidemiology of major drug indications in mature and developing markets. She holds a Master of Public Health degree from School of Public Health, Post-Graduate Institute of Medical Education and Research, and a Bachelor of Dental Surgery from MN DAV Dental College & has previously worked as a dental surgeon and as a Fellow at the National Health Systems Resource Centre, where she supported the preparation of National Health Accounts - Guidelines for India 2016.

  • Ravdeep Kaur started working in Decision Resources Inc. as an associate epidemiologist since December 31 st , 2015. She performs fully documented systematic reviews of both published and grey literature on the epidemiology of assigned diseases and their risk factors to estimate incidence/prevalence over a 10-30 year period. She produces analyses for pharmaceutical drug developers on the descriptive epidemiology of major drug indications in mature and developing markets. She holds a Master’s in Public Health degree from School of Public Health, Post-Graduate Institute of Medical Education and Research and a Bachelor’s in dental surgery from Rajiv Gandhi University of Health Sciences, India. She also has a Fellowship in Heath care Technology Assessment from World health Organization (WHO), India office.  Prior to joining Decision Resources, Ravdeep worked as a Consultant in Reproductive, Maternal, Child and Adolescent Health Program in a United States Agency for International development (USAID) funded project.   

Purchase Report

Recent reports:
You may also be interested in: